Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesofensine + Metoprolol in Type 2 Diabetes Mellitus
2015-005522-19Phase 2Completed
- Sponsor
- Saniona
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Tesofensine + Metoprolol with Placebo (2 arms). Primary endpoint: Change in mean 24-hour heart rate. Started Dec 2015; status: completed.
02
Drugs
tesofensinemetoprolol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-005522-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005522-19.